Cargando…
Proteomic profiling in schizophrenia: enabling stratification for more effective treatment
Schizophrenia is a heterogeneous psychiatric disorder characterized by an array of clinical manifestations. Although the best known manifestations include serious effects on mood and behavior, patients can also display co-morbidities, including immune system or metabolic abnormalities. Thorough char...
Autores principales: | Guest, Paul C, Martins-de-Souza, Daniel, Schwarz, Emanuel, Rahmoune, Hassan, Alsaif, Murtada, Tomasik, Jakub, Turck, Christoph W, Bahn, Sabine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706977/ https://www.ncbi.nlm.nih.gov/pubmed/23531373 http://dx.doi.org/10.1186/gm429 |
Ejemplares similares
-
The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia
por: Martins-de-Souza, Daniel, et al.
Publicado: (2012) -
Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders
por: Wesseling, Hendrik, et al.
Publicado: (2014) -
The role of proteomics in depression research
por: Martins-de-Souza, Daniel, et al.
Publicado: (2009) -
Proteomic analysis of post mortem brain tissue from autism patients: evidence for opposite changes in prefrontal cortex and cerebellum in synaptic connectivity-related proteins
por: Broek, Jantine AC, et al.
Publicado: (2014) -
Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function
por: Martins-de-Souza, Daniel, et al.
Publicado: (2012)